Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
3,443,864
-
Share change
-
+225,572
-
Total reported value
-
$26,621,413
-
Price per share
-
$7.73
-
Number of holders
-
36
-
Value change
-
+$1,872,133
-
Number of buys
-
13
-
Number of sells
-
17
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2019
As of 31 Mar 2019,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,443,864 shares.
The largest 10 holders included
BlackRock Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, SPHERA FUNDS MANAGEMENT LTD., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Sigma Planning Corp.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.